LLY

1,027.65

+0.36%↑

JNJ

199.6

+1.83%↑

ABBV

234.59

+0.96%↑

UNH

326.36

+1.55%↑

AZN

89.88

+0.83%↑

LLY

1,027.65

+0.36%↑

JNJ

199.6

+1.83%↑

ABBV

234.59

+0.96%↑

UNH

326.36

+1.55%↑

AZN

89.88

+0.83%↑

LLY

1,027.65

+0.36%↑

JNJ

199.6

+1.83%↑

ABBV

234.59

+0.96%↑

UNH

326.36

+1.55%↑

AZN

89.88

+0.83%↑

LLY

1,027.65

+0.36%↑

JNJ

199.6

+1.83%↑

ABBV

234.59

+0.96%↑

UNH

326.36

+1.55%↑

AZN

89.88

+0.83%↑

LLY

1,027.65

+0.36%↑

JNJ

199.6

+1.83%↑

ABBV

234.59

+0.96%↑

UNH

326.36

+1.55%↑

AZN

89.88

+0.83%↑

Search

Adverum Biotechnologies Inc

Open

SectorHealthcare

4.26 -0.7

Overview

Share price change

24h

Current

Min

4.23

Max

4.29

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+130.77% upside

News Sentiment

By Acuity

84%

16%

350 / 374 Ranking in Healthcare

Adverum Biotechnologies Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

24 paź 2025, 13:04 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly Agrees to Acquire Adverum Biotechnologies

24 paź 2025, 12:34 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly Says Transaction Is Expected to Close in the 4Q >LLY

24 paź 2025, 12:34 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly: Offer Also Includes 1 Non-Transferrable Contingent Value Right Entitling Holder to Receive Up to an Additional $8.91 Per CVR in Cash Upon the Achievement of 2 Milestones, for Total Potential Consideration of Up to $12.47/Shr >LLY

24 paź 2025, 12:33 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly to Launch Tender Offer to Acquire All Outstanding Shares of Adverum for $3.56/Shr >LLY

24 paź 2025, 12:30 UTC

Acquisitions, Mergers, Takeovers

Lilly To Acquire Adverum Biotechnologies >LLY ADVM

Peer Comparison

Price change

Adverum Biotechnologies Inc Forecast

Price Target

By TipRanks

130.77% upside

12 Months Forecast

Average 9.9 USD  130.77%

High 30 USD

Low 4 USD

Based on 6 Wall Street analysts offering 12 month price targets forAdverum Biotechnologies Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

6 ratings

3

Buy

3

Hold

0

Sell

Sentiment

By Acuity

350 / 374 Ranking in Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

$

help-icon Live chat